Ketamine, a drug approved for use as a general anesthetic and sedative, also appears to provide significant relief to patients with major depressive disorder, and those with chronic post-traumatic stress disorder (PTSD), according to two separate studies conducted by researchers at Icahn School of Medicine at Mount Sinai.
After launching a much-publicized campaign in October to promote the influenza vaccination for faculty, staff, and students, the Mount Sinai Health System will report a record rate of vaccination compliance to the New York State Department of Health (NYSDOH) for the 2013 – 2014 influenza season.
Typically, vaccination rates for health care workers are around 60 percent, according to the U.S. Centers for Disease Control and Prevention. The Health System’s overall compliance rate was 82 percent at the start of April.
One hundred twenty-seven members of Icahn School of Medicine at Mount Sinai’s Class of 2014 participated in the nation’s annual Match Day event on Friday, March 21. They gathered in the Annenberg West lobby to open their envelopes en masse and find out which residency programs they would be attending during the next phase of their training.
Icahn School of Medicine at Mount Sinai and The New York Academy of Medicine (NYAM) announced the formation of a new partnership to jointly study and address a number of significant health issues and policies that impact the lives of people who live in urban areas. NYAM is an historic and independent institution that has been advancing the health of people living in cities since its founding in 1847.
The Icahn School of Medicine at Mount Sinai, and National Jewish Health, the nation’s leading respiratory hospital, based in Denver, Colorado, have created a partnership to advance patient care and research in respiratory and related diseases. The Mount Sinai–National Jewish Health Respiratory Institute is expected to open on the Icahn School of Medicine campus in July.
The Mount Sinai Health System recently established the Mount Sinai Institute of Technology (MSIT), with a $5 million grant from the New York City Economic Development Corporation (NYCEDC). As part of Icahn School of Medicine at Mount Sinai, MSIT will train students to develop technology-based solutions that improve human health, and serve as an incubator for transformative, cost-effective discoveries.
Ten faculty members were named endowed professors at the 2013 Convocation Ceremony on Monday, September 30, an event that marks the beginning of the academic year for the Icahn School of Medicine at Mount Sinai. The honorees, renowned in their respective fields—including allergy and immunology, cancer research, neuroscience, nephrology, otolaryngology, translational genetics, and transplant immunology—comprised the largest group named at one time at Mount Sinai.
It was standing room only at the campuses of Beth Israel Medical Center, St. Luke’s and Roosevelt Hospitals, and New York Eye and Ear Infirmary for a series of Town Hall meetings at which the leaders of the Mount Sinai Health System presented their vision for the future and how the new system will address today’s health care challenges.